Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

Study found that fixed-dose plinabulin, a novel, non–GCSF small molecule with both anticancer and neutropenia-prevention effects, was non-inferior to pegfilgrastim in duration of severe neutropenia and will be compared with pegfilgrastim in phase 3 trial to confirm these results.

Source:

JAMA Oncology